Christopher J. Kirk

Business address
C/O Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco, CA, 94080
Top holdings (ownership)
KZR
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Christopher J. Kirk has filed 15 SEC EDGAR filings since 20 Jun 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 13 Jan 2025 09 Jan 2025 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 09 Nov 2023 08 Nov 2023 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 26 Jul 2023 24 Jul 2023 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 24 Jul 2023 20 Jul 2023 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 10 Jan 2023 08 Jan 2023 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 27 Jun 2022 23 Jun 2022 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 07 Jan 2022 05 Jan 2022 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 11 Jan 2021 08 Jan 2021 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 05 Feb 2020 04 Feb 2020 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 13 Jan 2020 12 Jan 2020 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 15 Aug 2019 13 Aug 2019 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 12 Aug 2019 09 Aug 2019 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 08 Jan 2019 06 Jan 2019 001-38542
4 Open Document Open Filing FORM 4 SUBMISSION 27 Jun 2018 25 Jun 2018 001-38542
3 Open Document Open Filing FORM 3 SUBMISSION 20 Jun 2018 20 Jun 2018 001-38542